Nifty
Sensex
:
:
21995.85
72488.99
-152.05 (-0.69%)
-454.69 (-0.62%)

Pharmaceuticals & Drugs

Rating :
45/99

BSE: 506919 | NSE: Not Listed

137.90
18-Apr-2024
  • Open
  • High
  • Low
  • Previous Close
  •  136.90
  •  139.90
  •  134.00
  •  135.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  90
  •  4.29
  •  157.00
  •  94.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 81.37
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 92.16
  • N/A
  • 1.23

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 61.27%
  • 2.47%
  • 29.93%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 6.33%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -4.63
  • -1.81
  • 13.85

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -16.38

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 143.25

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.08
  • 1.26
  • 1.26

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.32
  • 12.17
  • 12.17

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
26.51
19.88
33.35%
25.07
26.50
-5.40%
25.01
25.45
-1.73%
29.45
27.29
7.91%
Expenses
26.31
20.05
31.22%
24.87
24.88
-0.04%
25.14
25.43
-1.14%
27.67
25.25
9.58%
EBITDA
0.20
-0.18
-
0.20
1.62
-87.65%
-0.13
0.02
-
1.78
2.04
-12.75%
EBIDTM
0.76%
-0.88%
-4.88%
6.13%
-0.53%
0.07%
6.05%
7.48%
Other Income
0.37
0.27
37.04%
0.41
0.88
-53.41%
0.25
1.01
-75.25%
0.12
0.65
-81.54%
Interest
0.53
0.42
26.19%
0.49
1.07
-54.21%
0.41
0.39
5.13%
0.25
0.41
-39.02%
Depreciation
1.16
1.19
-2.52%
1.13
1.03
9.71%
1.11
0.89
24.72%
1.13
0.99
14.14%
PBT
-1.11
-1.52
-
-1.02
0.41
-
-1.40
-0.26
-
0.53
1.26
-57.94%
Tax
-0.06
0.26
-
0.11
0.35
-68.57%
0.26
0.57
-54.39%
0.18
0.33
-45.45%
PAT
-1.06
-1.77
-
-1.13
0.07
-
-1.66
-0.83
-
0.35
0.93
-62.37%
PATM
-3.99%
-8.93%
-10.84%
0.25%
-6.65%
-3.27%
1.18%
3.40%
EPS
-2.62
-3.74
-
-0.96
-1.09
-
-3.55
-2.74
-
-0.48
-1.24
-

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 23
Mar 22
Mar 21
Net Sales
106.04
101.28
127.20
68.64
Net Sales Growth
6.98%
-20.38%
85.31%
 
Cost Of Goods Sold
1,043.80
39.07
50.20
27.59
Gross Profit
-937.76
62.20
77.00
41.06
GP Margin
-884.35%
61.41%
60.53%
59.82%
Total Expenditure
103.99
97.96
108.36
60.52
Power & Fuel Cost
-
12.70
8.78
5.55
% Of Sales
-
12.54%
6.90%
8.09%
Employee Cost
-
11.73
12.51
8.71
% Of Sales
-
11.58%
9.83%
12.69%
Manufacturing Exp.
-
28.56
29.60
12.68
% Of Sales
-
28.20%
23.27%
18.47%
General & Admin Exp.
-
2.96
2.77
2.20
% Of Sales
-
2.92%
2.18%
3.21%
Selling & Distn. Exp.
-
2.01
3.70
2.45
% Of Sales
-
1.98%
2.91%
3.57%
Miscellaneous Exp.
-
0.90
0.81
1.35
% Of Sales
-
0.89%
0.64%
1.97%
EBITDA
2.05
3.32
18.84
8.12
EBITDA Margin
1.93%
3.28%
14.81%
11.83%
Other Income
1.15
2.28
2.60
0.96
Interest
1.68
2.20
1.74
1.76
Depreciation
4.53
4.24
4.02
4.61
PBT
-3.00
-0.84
15.68
2.70
Tax
0.49
1.35
3.97
1.36
Tax Rate
-16.33%
-160.71%
25.30%
50.37%
PAT
-3.50
-4.75
4.98
-0.33
PAT before Minority Interest
-5.32
-2.19
11.72
1.35
Minority Interest
-1.82
-2.56
-6.74
-1.68
PAT Margin
-3.30%
-4.69%
3.92%
-0.48%
PAT Growth
0.00%
-
-
 
EPS
-5.93
-8.05
8.44
-0.56

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Shareholder's Funds
69.20
59.58
54.13
Share Capital
5.90
4.92
4.92
Total Reserves
63.30
54.66
49.21
Non-Current Liabilities
15.08
13.23
16.50
Secured Loans
2.32
2.69
5.53
Unsecured Loans
2.00
0.00
0.00
Long Term Provisions
0.27
0.43
0.38
Current Liabilities
27.54
33.01
33.12
Trade Payables
10.14
5.46
14.53
Other Current Liabilities
10.99
13.79
8.94
Short Term Borrowings
4.55
11.67
6.32
Short Term Provisions
1.85
2.09
3.34
Total Liabilities
152.29
144.33
136.19
Net Block
84.52
68.30
71.39
Gross Block
129.77
109.97
81.94
Accumulated Depreciation
45.25
41.67
10.55
Non Current Assets
88.96
81.42
75.15
Capital Work in Progress
0.49
9.38
0.16
Non Current Investment
0.08
0.22
1.21
Long Term Loans & Adv.
3.30
2.99
1.82
Other Non Current Assets
0.57
0.53
0.56
Current Assets
63.34
62.91
61.04
Current Investments
0.00
0.00
0.75
Inventories
31.32
23.84
27.47
Sundry Debtors
19.87
13.55
16.61
Cash & Bank
4.37
8.67
6.22
Other Current Assets
7.77
3.84
8.59
Short Term Loans & Adv.
0.98
13.00
1.40
Net Current Assets
35.80
29.90
27.92
Total Assets
152.30
144.33
136.19

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Cash From Operating Activity
-8.62
18.50
0.00
PBT
-0.84
15.69
0.00
Adjustment
5.65
5.21
0.00
Changes in Working Capital
-10.96
3.23
0.00
Cash after chg. in Working capital
-6.15
24.13
0.00
Interest Paid
0.00
0.00
0.00
Tax Paid
-2.47
-5.63
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
Cash From Investing Activity
1.25
-21.79
0.00
Net Fixed Assets
-3.46
-9.83
Net Investments
0.03
1.11
Others
4.68
-13.07
Cash from Financing Activity
5.78
0.33
0.00
Net Cash Inflow / Outflow
-1.59
-2.96
0.00
Opening Cash & Equivalents
2.31
5.27
0.00
Closing Cash & Equivalent
0.72
2.31
0.00

Financial Ratios

Standalone /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Book Value (Rs.)
117.28
121.17
105.62
ROA
-1.48%
8.35%
0.99%
ROE
-3.40%
20.61%
2.49%
ROCE
1.72%
24.00%
6.53%
Fixed Asset Turnover
0.84
1.33
0.84
Receivable days
60.23
43.28
88.31
Inventory Days
99.41
73.62
146.06
Payable days
72.86
72.68
192.25
Cash Conversion Cycle
86.77
44.22
42.12
Total Debt/Equity
0.17
0.29
0.26
Interest Cover
0.62
10.03
2.53

News Update:


  • Makers Laboratories - Quarterly Results
    13th Feb 2024, 12:16 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.